In this line, we previously demonstrated that LUV-TRAIL was able to activate DR5 in a more efficient way than sTRAIL due to its capacity to contribute to DR5 clustering on the cell surface in colon cancer cells [23]. This evidence concerns the gene TNFRSF10B and malignant colon neoplasm.